Literature DB >> 31215812

Predicting functional recovery after mild traumatic brain injury: the SHEFBIT cohort.

James Booker1, Saurabh Sinha2, Kishor Choudhari2, Jeremy Dawson3, Rajiv Singh1,4.   

Abstract

Background: Current prognostic models for mild Traumatic Brain Injury (mTBI) are unsatisfactory in identifying patients at risk of an unfavorable outcome following injury. Objective: To identify prognostic indicators of recovery one-year following mTBI.
Methods: A large population (n = 596) of patients with mTBI were prospectively recruited following admission to the Emergency Department. Data were collected at brain injury clinics at 8-10 weeks and one-year after injury. Functional recovery at one year was assessed using the Glasgow Outcome Scale-Extended (GOSE).
Results: A follow-up rate of 92% was achieved. The most common aetiologies of mTBI were falls (n = 222) and road traffic collisions (n = 154). Distribution of GCS was 15 (n = 363), 14 (n = 156) and 13 (n = 77). Ordinal regression analysis found that psychiatric history (p < .001), alcohol intoxication (p = .011), assault (p = .022) and GCS < 15 (p =< 0.001), were associated with worse outcome. An abnormal CT scan was not a predictor of disability.
Conclusion: Patients with a previous psychiatric history, GCS < 15, etiology of assault, and alcohol intoxication result in worse long-term outcomes after mTBI. The predictors identified should be implemented when developing a future-validated a prognostic model for mTBI recovery.

Entities:  

Keywords:  Mild traumatic brain injury; post-concussion symptoms; prognosis; recovery

Mesh:

Year:  2019        PMID: 31215812     DOI: 10.1080/02699052.2019.1629626

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  1 in total

1.  "Can differences in hospitalised mild traumatic brain injury (mTBI) outcomes at 12 months be predicted?"

Authors:  Thomas Jackson Humphries; Saurabh Sinha; Jeremy Dawson; Fiona Lecky; Rajiv Singh
Journal:  Acta Neurochir (Wien)       Date:  2022-03-28       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.